# Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures

> **NCT00250302** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 24 (estimated)

## Conditions studied

- Tibial Fracture

## Interventions

- **PROCEDURE:** autologous mesenchymal stem cells implantation

## Key facts

- **NCT ID:** NCT00250302
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250302, "Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00250302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*